Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression-Reference-Cited by-同舟云学术

Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression

Published:2020-05-28 Issue:10 Volume:26 Page:1268-1269
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Carandini Tiziana¹^ORCID,Pietroboni Anna Margherita¹^ORCID,Sacchi Luca¹²,De Riz Milena Alessandra¹,Pozzato Mattia¹²,Arighi Andrea¹,Fumagalli Giorgio Giulio¹,Martinelli Boneschi Filippo¹²^ORCID,Galimberti Daniela¹²,Scarpini Elio¹²

Affiliation:

1. Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy

2. University of Milan, Milan, Italy

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458520926459

Reference5 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

2. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

3. Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients

4. Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study;Multiple Sclerosis and Related Disorders;2024-10

2. Outcomes of COVID-19 disease and its effect on disability in patients with multiple sclerosis and other allied demyelinating disorders;Clinical Neurology and Neurosurgery;2024-02

3. Flu-like syndrome due to interferon-beta injections does not increase anxiety, depression, and lost working days in multiple sclerosis patients during the Sars-CoV-2 pandemic;Clinical Neurology and Neurosurgery;2023-09

4. Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review;Viral Immunology;2023-08-01

5. The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study;Multiple Sclerosis and Related Disorders;2022-09